The Pediatric Infectious Disease Journal · 1997 · 16 citations · 8 references
MedicineInfectious DiseasesInternal MedicineDiagnostic MicrobiologyImmunizationMedical MicrobiologyBacterial InfectionsBone InfectionsOsteomyelitisTuberculosis Diagnostic TestingTuberculosis VaccinationErythema InfectiosumImmunization With Bacille Calmette-guérinMycobacterial Bone InfectionMycobacterium Bovis DetectionMycobacterium Tuberculosis InfectionTuberculosis Diagnostics
Osteomyelitis is a rare complication of Bacille Calmette-Guérin (BCG) vaccination. The frequency is assumed to be approximately 1 per million vaccinations.1 BCG osteomyelitis is also reported as a complication of intravesical BCG therapy for bladder carcinoma.2 Although the definitive diagnosis is made by recovery of Mycobacterium bovis BCG strain from the focus, the recovery and the definitive identification of M. bovis BCG are not easy.3 We report the first case of BCG osteomyelitis diagnosed genetically by polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP). Case report. A 1-year-old Japanese girl was admitted to a hospital in July, 1995, with swelling and slight tenderness of her left forearm for 2 months. She had no history of contact with tuberculous individuals and no history of recurrent infections. She had received BCG vaccine on the left upper arm in July, 1994. Regional lymphadenitis was not found after vaccination. The tuberculin skin test (purified tuberculin; Nihon BCG Co., Tokyo, Japan) produced an area of visible erythema 24 mm in diameter within 48 h. Routine laboratory findings were as follows: white blood cell count, 8580/mm3; erythrocyte sedimentation rate, 20 mm/h; C-reactive protein, 0.2 mg/dl. Other laboratory studies were normal. Magnetic resonance imaging of the left forearm showed a subfascial abscess and a lytic lesion of the proximal radius. At surgery the subfascial abscess was drained. Because no fistula was found on the radius, curettage of the radius was not carried out. Histologic examination of the excised tissue showed epithelioid cell granulomas with caseous necrosis and Langhans-type giant cells. Acid-fast stain of the specimen revealed several positive bacilli. The patient was suspected of having tuberculous infection and was transferred to our university hospital in August. After a needle biopsy of the radius, treatment was started with isoniazid (15 mg/kg per day), rifampin (10 mg/kg per day) and streptomycin (20 mg/kg, three times a week) for 2 months. Because the magnetic resonance imaging findings of the subfascial abscess and lytic lesion of the radius did not improve, curettage of the radius was carried out in October. The administration of isoniazid and rifampin was continued until July, 1996, after which she has been well without evidence of recurrence. Materials and methods.Mycobacterium tuberculosis NIHJ 1633 (ATCC 27294) and M. bovis NIHJ 1607 were provided by Dr. T. Yamazaki (National Institute of Health, Tokyo, Japan). The bacterial colonies and freeze-dried BCG vaccine (Nihon BCG) were boiled in 10 mM Tris-HCl-1 mM EDTA, pH 8.0, for 10 min and used for PCR. DNA was extracted from the biopsy specimen and suspended in 10 mM Tris-HCl-1 mM EDTA, pH 8.0. PCR was performed with 2 μl of boiled lysate or DNA solution as described.4 The primers used for the MPB70 gene specific for the M. tuberculosis complex were TB-1A and TB-1B,5 and those for amplification of the major polymorphic tandem repeat (MPTR) were MtMPTR.541p and MtMPTR.883n,6 as described. The SSCP method was performed as described.4, 7 The dilution of the amplified MPTR-PCR products was 1:20 to 1:80. The electrophoresis was performed at 35 W for 3 h. DNA was detected with a chemiluminescent substrate system (Phototope-Star Detection Kit®, New England Biolabs, Inc., Beverly, MA). The nucleotide sequences of the PCR products were determined with the Sequenase Images Non-Isotopic DNA Sequencing Kit® (Amersham Life Science, Cleveland, OH). Results. We amplified the MPB70 gene specific for the M. tuberculosis complex from the biopsy specimen but failed to determine whether the osteomyelitis was caused by M. tuberculosis or M. bovis BCG. Then we amplified the MPTR from the specimen and compared it with the standard strain of M. tuberculosis, M. bovis and BCG vaccine using SSCP analysis. The PCR product from the specimen showed the same pattern as did the BCG vaccine but clearly different pattern from those of the standard and clinical isolates of M. tuberculosis and M. bovis. The sequencing of each MPTR PCR product confirmed this difference. M. bovis BCG grew from a culture of the specimen. The species was identified by the positive niacin test and by the absence of proliferation on the thiophene-carboxylic acid hydrazide plate. The pattern of SSCP analysis and the sequence of MPTR PCR product from the isolate were the same as those from BCG vaccine and the biopsy specimen. Discussion. Osteomyelitis is a rare complication of BCG vaccination1 and intravesical BCG therapy for bladder carcinoma.2 Most cases of BCG osteomyelitis after vaccination were reported in Europe,8, 9 and the incidence has been estimated as 1.11 per million vaccinations.3 Lotte et al.3 reported that 160 of 251 BCG osteomyelitis cases (64%) were found to be positive on smears or culture by bacteriologic examination and that BCG strains were identified in 124 cases (49%). Although rapid diagnosis of tuberculosis with PCR has become available, this method cannot discriminate species among the M. tuberculosis complex (M. tuberculosis, M. bovis, and M. bovis BCG).5 Frothingham6 reported the differentiation of strains in the M. tuberculosis complex by DNA sequence polymorphisms. We used the PCR-SSCP method to identify the M. bovis BCG strain on the basis of the polymorphisms. Our results showed that the osteomyelitis of the patient was caused by M. bovis BCG, and we suggest that this method is useful for the rapid diagnosis of M. bovis BCG osteomyelitis. Acknowledgments. We thank Dr. T. Mori, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, for the biological differentiation of M. bovis BCG. Jun-Ichiro Nishi, M.D. Akira Kamenosono, M.D. Krishna Pada Sarker, M.Phil. Shinji Yoshino, M.D. Junko Ikei, M.D. Yukihisa Matsuda, M.D. Departments of Pediatrics (JN, AK), Laboratory; Molecular Medicine (KPS) and Orthopedic; Surgery (SY); Faculty of Medicine; Kagoshima University; Imakyurei General Hospital (JI, YM); Kagoshima, Japan
8
Use of polymerase chain reaction for rapid diagnosis of tuberculosis
Debby Cousins, Steve D. Wilton, B Francis et al. · Journal of Clinical Microbiology · 1992 · 182 citations · Full text